secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vaxart, Inc. (VXRT)
CIK:        0000072444
Form:       8-K
Filed at:   2025-10-10T23:59:59+00:00
Accession:  0001437749-25-030868
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

BARDA narrows Vaxart COVID vaccine pact; 5,000-subject follow-up continues
--------------------------------------------------------------------------

- Received Follow-Up Notice on Oct 8: BARDA intends to delimit Project Agreement excluding paused work.
- Approximately 5,000 participants already enrolled in Phase 2b trial will continue to be followed.
- Funding for follow-up of enrolled participants will continue; paused work no longer supported.
- Company believes data from enrolled cohort will provide useful insights to advance COVID program.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/72444/000143774925030868/0001437749-25-030868-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/72444/000143774925030868/vxrt20251010_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-030868

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer